In late May, a Chicago jury sided with GSK and Boehringer Ingelheim on Zantac cancer claims in Illinois.
Pfizer, Sanofi-Aventis, and Boehringer spokespersons did not respond to Law360 inquiries about the Connecticut case Tuesday. An attorney for the plaintiffs also did not respond to a message.
The Connecticut plaintiffs are all represented by Brenden P. Leydon of Wocl Leydon LLC.
Pfizer is represented by James O. Craven and James I. Glasser of Wiggin & Dana LLP.
GlaxoSmithKline is represented by Robert R. Simpson and Lauren R. Greenspoon of Shook Hardy & Bacon LLP.
Sanofi-Aventis is represented by Joseph W. Martini and Janna D. Eastwood of Spears Manning & Martini LLC.
Boehringer is represented by Patrick M. Fahey and Jaime A. Welsh of Shipman & Goodwin LLP.
The cases are Linda Carrano et al. v. Boehringer Ingelheim Pharmaceuticals Inc. et al., case number UWY-CV23-6075772-S, and George Morrison et al. v. Boehringer Ingelheim Pharmaceuticals Inc. et al., case number UWY-CV24-6076005-S, on the Complex Litigation Docket of the Connecticut Superior Court at Waterbury.
